NervGen Pharma Corp.

    NervGen Pharma Corp.

    TTSXV:NGEN
    - -
    CAD
    - -
    - -
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Basic EPS, GAAP
    - -
    -0.05
    -0.38
    -0.35
    -0.32
    -0.39
    -0.38
    -0.36
    - -
    -0.61
    Free Cash Flow per Basic Share
    - -
    -0.04
    -0.31
    -0.2
    -0.21
    -0.34
    -0.19
    -0.25
    - -
    -0.27
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    - -
    0.09
    0.16
    0.02
    0.19
    0.03
    -0.32
    -0.32
    - -
    -0.61
    Tangible Book Value per Share
    - -
    0.07
    0.21
    0.17
    0.42
    0.25
    -0.04
    0.03
    - -
    0.04
    Basic Weighted Avg Shares
    27
    27
    26
    32
    39
    53
    59
    67
    - -
    72
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Net Income, GAAP
    - -
    -1
    -10
    -11
    -13
    -21
    -22
    -24
    -44
    -44
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Working Capital
    - -
    2
    5
    5
    16
    13
    -3
    2
    3
    3
    LT Debt
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Total Equity
    - -
    3
    6
    6
    17
    13
    -2
    3
    3
    3
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    -294.41
    -467.77
    -318.97
    -460.73
    - -
    - -
    - -
    - -

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    73
    73
    80
    Market Capitalization
    244
    235
    552

    Working Capital

    CAD

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    Total Current Assets
    16
    13
    23
    Cash, Cash Equivalents & STI
    16
    11
    22
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    18
    16
    20
    Payables & Accruals
    4
    4
    3
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    -28.82%
    34.94%
    Free Cash Flow
    - -
    34.67%
    15.78%
    Net Income, GAAP
    - -
    34.98%
    81.93%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.08
    -0.08
    -0.07
    - -
    -0.38
    2024
    -0.04
    -0.11
    -0.08
    - -
    -0.36
    2025
    -0.06
    -0.13
    -0.06
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business